GE Healthcare of Chalfont St. Giles, U.K., has inked an agreement with CardioDx of Palo Alto, CA, to codevelop diagnostic technologies to improve the care and management of patients with cardiovascular disease.
As part of the pact, GE has invested $5 million from its GE Healthymagination Fund in CardioDx, which develops genomic tests to aid in the assessment and tailoring of care for individuals with cardiovascular diseases such as coronary artery disease, cardiac arrhythmias, and heart failure.
Pascale Witz, president and CEO of GE Healthcare's Medical Diagnostics business, said the partnership gives GE access to new technologies in diagnostics, which will complement the company's current offerings.
Related Reading
GE's German IT unit chooses Matrox boards, May 12, 2010
GE begins 1st Optima MR450w installs, April 28, 2010
GE, Nycomed extend partnership, April 28, 2010
GE targets ultrasound energy reduction, April 26, 2010
Report: GE ignored Omniscan warnings, April 19, 2010
Copyright © 2010 AuntMinnie.com
